Frank Irvine Comer

Title: Frank Irvine Comer: Innovator in Antibody Molecules

Introduction

Frank Irvine Comer is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody molecules that have potential applications in cancer treatment.

Latest Patents

Frank Irvine Comer holds 1 patent for his work on antibody molecules and conjugates. His patent focuses on antibody molecules that bind to the epidermal growth factor receptor (EGFR) and/or c-Met. These antibody molecules and their conjugates are designed to be utilized in therapeutic applications, especially in the treatment of cancer.

Career Highlights

Frank is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca involves research and development in innovative therapies that target critical areas in oncology.

Collaborations

Some of his notable coworkers include Yariv Mazor and Srinath Kasturirangan, who contribute to the collaborative efforts in advancing research in antibody therapies.

Conclusion

Frank Irvine Comer is a distinguished inventor whose work in antibody molecules is paving the way for new cancer treatments. His contributions to biotechnology continue to have a significant impact on the medical field.